A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Innovative Inogen One G5™ Portable Oxygen Concentrator Released into the Market

What To Know

  • The Inogen One G5 represents a step forward in innovation, as it is the highest oxygen output per pound of weight of any portable oxygen concentrator currently available in the homecare market in the United States.
  • The Inogen One G5 has been released for sale to oxygen therapy patients in the Company's domestic direct-to-consumer sales channel and is expected to be made available to additional sales channels, including domestic and international business-to-business channels (pending receipt of any required foreign regulatory approvals), through a controlled rollout process over the coming months.

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the release to market of its innovative Inogen One G5 portable oxygen concentrator.

At only 4.7 pounds and 6 flow settings, the Inogen One G5 portable oxygen concentrator is the most balanced portable oxygen concentrator Inogen has ever created to meet the needs of oxygen therapy patients and home medical equipment providers – for use at home, away, and for travel.

The Inogen One G5 represents a step forward in innovation, as it is the highest oxygen output per pound of weight of any portable oxygen concentrator currently available in the homecare market in the United States. With 1,260 ml of oxygen production capacity and Inogen’s standard Intelligent Delivery Technology®, the Inogen One G5 was designed to meet the clinical needs of 95% of patients that express an interest in Inogen’s products for long-term oxygen therapy. Other patient-preferred features include a long battery life of up to 13 hours with the optional double battery, access to Inogen Connect, a large LCD screen, and very quiet operation.

It is Inogen’s mission to push the boundaries of conventional design and to develop innovative and patient-preferred oxygen technology to help patients reclaim their freedom and independence.

“The Inogen One G5 exemplifies Inogen’s spirit of innovation and dedication to designing products specifically for the end consumer, the oxygen therapy user, while also taking into account the needs of the homecare provider,” said Scott Wilkinson, Inogen’s CEO. “We are extremely proud of the level of innovation that we are delivering to patients, and we look forward to hearing about the lives changed because of the Inogen One G5.”

The Inogen One G5 has been released for sale to oxygen therapy patients in the Company’s domestic direct-to-consumer sales channel and is expected to be made available to additional sales channels, including domestic and international business-to-business channels (pending receipt of any required foreign regulatory approvals), through a controlled rollout process over the coming months.

Additional specifications for the Inogen One G5 can be found on page 2:

Weight 4.7 lbs. (includes single battery)
Size Length: 7.19″
Width: 3.26″
Height: 8.15″ (includes single battery)
Oxygen Flow Pulse dose delivery system
6 flow settings 1, 2, 3, 4, 5, 6
Power AC Power Supply 100-240V, 50-60Hz
(auto sensing to allow worldwide use)
DC Power Cable: for mobile use in car
Battery Duration (single battery): up to 6.5 hours
Recharge up to 3 hours with AC or DC power
Duration (double battery): Up to 13 hours
Noise Level 38 dBA*
Operation Simple control functions and easy-to-read LCD display
Use Designed for 24/7 use
*At flow setting 2
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy